NNVC - NanoViricides, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc.

NNVC 1.200

+10.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rawnoc who wrote (3211)	12/9/2014 1:21:39 PM
From: Puffer1	Read Replies (1) of 12873

NNVC hired a specialist consulting group to put together and submit the orphan application. I guess they are a fruad too? This just gets ridiculous... "NanoViricides, Inc. (OTC BB: NNVC) (the "Company") announced today that the European associates of the consulting firm Cote´ Orphan Consulting, on behalf of NanoViricides, have submitted an Orphan Drug Application to the European Medicines Agency (EMA) for DengueCide™, a drug candidate for the treatment of dengue and dengue hemorrhagic fever."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next